Home Newsfeeds Wolfe Research Downgrades AbbVie to Peer Perform

Wolfe Research Downgrades AbbVie to Peer Perform

Wolfe Research analyst Tim Anderson downgrades AbbVie (NYSE:ABBV) from Outperform to Peer Perform.

byBenzinga Newsdesk

February 22, 2023

1 minute read

Wolfe Research analyst Tim Anderson downgrades AbbVie (NYSE:ABBV) from Outperform to Peer Perform.

Tesla To The Moon? Why Elon Musk Hints Nvidia’s Large-Cap Dominance Is Only ‘For Now’

By Shanthi Rexaline

May 26, 2:29 AM

Nvidia Corp. (NASDAQ:NVDA) gave the markets a much-needed lift with its stellar quarterly results and the stock promptly…

AMD

Apartment Income REIT Q1 FFO $0.59

By Michael Horton

February 9, 6:22 PM

Apartment Income REIT (NYSE:AIRC) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $0.11 by 436.36 percent. This is a 3.51 percent increase over earnings of $0.57 per share from

AIRC

Traders Circulate Barclays Note Saying Catalent Had Their 483s Cleared Over The Weekend. The FDA Cleared Both The Belgium And Bloomington Facilities 483s With Voluntary Action Indicated Designations; A Minimally Acceptable State Of Compliance Was Met

By Benzinga Newsdesk

November 28, 1:56 PM

Barclays saying that CTLT had their 483s were cleared over the weekend the FDA cleared both the Belgium and Bloomington facilities’ 483s over the weekend with Voluntary Action Indicated (VAI) designations.

CTLT